.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Fish and Richardson
Chubb
Citi
Julphar
Boehringer Ingelheim
Farmers Insurance
UBS
Teva

Generated: November 19, 2017

DrugPatentWatch Database Preview

Atovaquone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for atovaquone and what is the scope of atovaquone freedom to operate?

Atovaquone
is the generic ingredient in five branded drugs marketed by Glaxosmithkline Llc, Paddock Llc, Amneal Pharms, Glenmark Generics, Mylan Pharms Inc, and Glaxosmithkline, and is included in seven NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for atovaquone. Three suppliers are listed for this compound.

Pharmacology for atovaquone

Medical Subject Heading (MeSH) Categories for atovaquone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms
ATOVAQUONE
atovaquone
SUSPENSION;ORAL202960-001Mar 18, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
ATOVAQUONE
atovaquone
SUSPENSION;ORAL207833-001Apr 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL091211-001Jan 12, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
MALARONE PEDIATRIC
atovaquone; proguanil hydrochloride
TABLET;ORAL021078-002Jul 14, 2000ABRXYesNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
MALARONE
atovaquone; proguanil hydrochloride
TABLET;ORAL021078-001Jul 14, 2000ABRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL202362-001May 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL202362-002May 27, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline Llc
MEPRON
atovaquone
TABLET;ORAL020259-001Nov 25, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline Llc
MEPRON
atovaquone
SUSPENSION;ORAL020500-001Feb 8, 1995ABRXYesYes► Subscribe► SubscribeY► Subscribe
Glenmark Generics
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL091211-002Apr 6, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: atovaquone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc
MEPRON
atovaquone
SUSPENSION;ORAL020500-001Feb 8, 1995► Subscribe► Subscribe
Glaxosmithkline Llc
MEPRON
atovaquone
TABLET;ORAL020259-001Nov 25, 1992► Subscribe► Subscribe
Glaxosmithkline Llc
MEPRON
atovaquone
SUSPENSION;ORAL020500-001Feb 8, 1995► Subscribe► Subscribe
Glaxosmithkline Llc
MEPRON
atovaquone
SUSPENSION;ORAL020500-001Feb 8, 1995► Subscribe► Subscribe
Glaxosmithkline Llc
MEPRON
atovaquone
TABLET;ORAL020259-001Nov 25, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Covington
Dow
McKesson
Moodys
Teva
Colorcon
Citi
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot